Tip os
Log ind
DNB sees huge potential in Norwegian biotech cluster

Norway-based financial services group DNB believes the Oslo Cancer Cluster has developed into one of Europe’s top biotech hubs. Norway’s life science industry is generally speaking more mature than a few years ago, says the group’s senior advisor for healthcare.

ANNONCE


ANNONCE